tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

FATE Stock Latest News

Fate Therapeutics Announces Executive Leadership Transition
Company AnnouncementsFate Therapeutics Announces Executive Leadership Transition
12d ago
8K
FATE
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
19d ago
FATE
OTLK
Fate Therapeutics presents new data from FT819 study
PremiumThe Fly
Fate Therapeutics presents new data from FT819 study
1M ago
FATE
Fate Therapeutics Announces Leadership Transition for 2025
PremiumCompany Announcements
Fate Therapeutics Announces Leadership Transition for 2025
2M ago
8K
FATE
Fate Therapeutics CEO Wolchko to retire
PremiumThe Fly
Fate Therapeutics CEO Wolchko to retire
2M ago
FATE
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
2M ago
PLX
ACRS
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
PLX
ACRS
Fate upgraded to Neutral at BofA after FT819 achieves DORIS remission
Premium
The Fly
Fate upgraded to Neutral at BofA after FT819 achieves DORIS remission
2M ago
FATE
Fate Therapeutics upgraded to Neutral from Underperform at BofA
PremiumThe Fly
Fate Therapeutics upgraded to Neutral from Underperform at BofA
2M ago
FATE
Stifel ‘impressed’ with results for Fate Therapeutics’ first FT819 LN patient
PremiumThe Fly
Stifel ‘impressed’ with results for Fate Therapeutics’ first FT819 LN patient
2M ago
FATE
Fate Therapeutics’ FT522 shows efficacy in Phase 2 B-cell lymphoma trial
PremiumThe Fly
Fate Therapeutics’ FT522 shows efficacy in Phase 2 B-cell lymphoma trial
2M ago
FATE
Fate Therapeutics presents 6-month data on first lupus patient
PremiumThe Fly
Fate Therapeutics presents 6-month data on first lupus patient
2M ago
FATE
Fate Therapeutics’ Stock Volatility: Impact of Partnerships and Regulatory Challenges
PremiumCompany AnnouncementsFate Therapeutics’ Stock Volatility: Impact of Partnerships and Regulatory Challenges
2M ago
FATE
Fate Therapeutics Unveils Q3 2024 Financial Highlights
Premium
Company Announcements
Fate Therapeutics Unveils Q3 2024 Financial Highlights
2M ago
FATE
Fate Therapeutics reports Q3 EPS (40c), consensus (43c)
Premium
The Fly
Fate Therapeutics reports Q3 EPS (40c), consensus (43c)
2M ago
FATE
Is FATE a Buy, Before Earnings?
PremiumPre-Earnings
Is FATE a Buy, Before Earnings?
3M ago
FATE
Fate Therapeutics Strengthens Legal Safeguards for Leadership
PremiumCompany Announcements
Fate Therapeutics Strengthens Legal Safeguards for Leadership
5M ago
8K
FATE
Fate Therapeutics reports Q2 EPS (33c), consensus (47c)
PremiumThe Fly
Fate Therapeutics reports Q2 EPS (33c), consensus (47c)
5M ago
FATE
Fate Therapeutics Appoints AI Expert to Enhance Board
PremiumCompany Announcements
Fate Therapeutics Appoints AI Expert to Enhance Board
6M ago
8K
FATE
Fate Therapeutics appoints Neely Mozaffarian to board of directors
PremiumThe FlyFate Therapeutics appoints Neely Mozaffarian to board of directors
6M ago
FATE
FATE Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
FATE Earnings this Week: How Will it Perform?
6M ago
FATE
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
ADVM
ALLO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >